Wells Fargo
THRD

Wells Fargo’s Third Harmonic Bio THRD Stock Holding History

Wells Fargo’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,118
Closed -$87.5K – 7393
2025
Q2 		$87.5K Buy
16,118
+2,962
+23% +$14.8K ﹤0.01% 5276
2025
Q1 		$45.7K Buy
13,156
+1,519
+13% +$7.37K ﹤0.01% 5433
2024
Q4 		$120K Buy
11,637
+2,535
+28% +$31.6K ﹤0.01% 5100
2024
Q3 		$123K Buy
9,102
+391
+4% +$4.84K ﹤0.01% 4891
2024
Q2 		$113K Buy
8,711
+1,850
+27% +$22.9K ﹤0.01% 4860
2024
Q1 		$64.8K Buy
6,861
+885
+15% +$8.6K ﹤0.01% 5153
2023
Q4 		$65.6K Buy
5,976
+1,183
+25% +$9.37K ﹤0.01% 5157
2023
Q3 		$30.6K Sell
4,793
-2,570
-35% -$15.7K ﹤0.01% 5424
2023
Q2 		$35.4K Buy
7,363
+5,042
+217% +$24K ﹤0.01% 5564
2023
Q1 		$9.56K Buy
+2,321
New +$9.86K ﹤0.01% 5878

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wells Fargo's THRD Position: Q3 2025 in Review

Wells Fargo sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 16,118 shares — an estimated $87.5K sold.

Wells Fargo first reported a position in THRD in Q1 2023 and held it in 10 quarters. The position peaked at $123K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Wells Fargo reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 16,118 Third Harmonic Bio shares in Q3 2025, an estimated $87.5K.
  • Wells Fargo first reported a position in Third Harmonic Bio in Q1 2023 and held it in 10 quarters.
  • Wells Fargo's Third Harmonic Bio position peaked at $123K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.